Evidence map›Paper›PMID 34563030›Full record

ReviewGels (Basel, Switzerland)2021

3D Bioprinting of Hydrogels for Cartilage Tissue Engineering.

Jianghong Huang, Jianyi Xiong, Daping Wang, Jun Zhang, Lei Yang, Shuqing Sun, Yujie Liang

Abstract readReview
In one paragraph

Review in Gels (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Multiscale embedded printing of engineered human tissue and organ equivalents.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jianghong HuangDepartment of Orthopedics, Shenzhen Second People's Hospital (Health Science Center, First Affiliated Hospital of Shenzhen University), Shenzhen 518035, China.ORCID 0000-0001-8660-6895
Jianyi XiongDepartment of Orthopedics, Shenzhen Second People's Hospital (Health Science Center, First Affiliated Hospital of Shenzhen University), Shenzhen 518035, China.
Daping WangDepartment of Orthopedics, Shenzhen Second People's Hospital (Health Science Center, First Affiliated Hospital of Shenzhen University), Shenzhen 518035, China.
Jun ZhangTsinghua University Shenzhen International Graduate School, Shenzhen 518055, China.
Lei YangDepartment of Orthopedics, Shenzhen Second People's Hospital (Health Science Center, First Affiliated Hospital of Shenzhen University), Shenzhen 518035, China.
Shuqing SunInstitute of Biomedicine and Health Engineering, Tsinghua University Shenzhen International Graduate School, Shenzhen 518055, China.
Yujie LiangDepartment of Child and Adolescent Psychiatry, Shenzhen Kangning Hospital, Shenzhen Mental Health Center, Shenzhen 518020, China.ORCID 0000-0002-0860-4859

Funding

Shenzhen Science and Technology Projects GJHZ20190820115203714Shenzhen Science and Technology Projects JSGG20191129094218565
6 · The paper itself

Abstract

Three-dimensional (3D) bioprinting is an emerging technology based on 3D digital imaging technology and multi-level continuous printing. The precise positioning of biological materials, seed cells, and biological factors, known as "additive biomanufacturing", can provide personalized therapy strategies in regenerative medicine. Over the last two decades, 3D bioprinting hydrogels have significantly advanced the field of cartilage and bone tissue engineering. This article reviews the development of 3D bioprinting and its application in cartilage tissue engineering, followed by a discussion of the current challenges and prospects for 3D bioprinting. This review presents foundational information on the future optimization of the design and manufacturing process of 3D additive biomanufacturing.

Indexed as

3D bioprintingadditive manufacturingbioinkscartilage tissue engineeringhydrogel

Identifiers

PMID34563030
PMCPMC8482067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.